Loading

GOVERNMENT

  • by Justin Strekal, NORML Political Director December 8, 2017

    Medical marijuanaCongressional leadership voted to enact a two-week continuing resolution that maintains present federal spending levels and priorities through December 22, 2017. The resolution extends medical cannabis patient protections imposed by the Rohrabacher-Blumenauer amendment until that date.

    The amendment, which has been in place since 2014, maintains that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

    “While we are pleased that these critical protections will continue, two weeks is not enough certainty for the millions of Americans who rely on medical marijuana for treatment and the businesses who serve them. As Congress works out a long-term funding bill, it must also include these protections. And ultimately, Congress must act to put an end to the cycle of uncertainty and permanently protect state medical marijuana programs—and adult use—from federal interference. The American people have spoken. It’s past time that Congress catch up.” – Representative Earl Blumenauer (D-OR)

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    Send a message to your federal lawmakers in support of continuing these protections beyond December 22nd by clicking here. 

  • by Dale Gieringer, Director of California NORML December 5, 2017

    marijuana_growerCal NORML has sent comments to state regulators at the CA Department of Food and Agriculture regarding their emergency licensing regulations for cannabis cultivation.

    “We are concerned that the CDFA’s proposed emergency regulations on cannabis cultivation licensing fail to limit the total amount of acreage that any one applicant may accumulate. This opens the doors to large-scale, industrial mega- grows that could monopolize California’s limited available acreage, exacerbate environmental harm, and stifle participation by smaller growers,” CaNORML wrote.

    “California does not need any new, large-scale, industrial grows,” the comments continue. “Rather, it needs to accommodate existing growers into the legal market with as few adverse impacts as possible. The total acreage needed to supply the state’s entire adult- use market is only about 1,000 outdoor acres, assuming one ounce/sq ft average yield and 2.5 million lbs. total state demand. It’s essential that acreage be allocated in a way that is fair to the many existing modest-scale growers who wish to participate and not thrown away on new industrial mega-grows.”

    CaNORML suggests a licensing priority scheme, designed to minimize environmental impacts, which would allocate licenses in the following order:

    (1) outdoor licenses of all types, up to a total of no more than one acre per applicant;
    (2) indoor mixed lighting licenses, up to no more than one acre total per applicant;
    (3) indoor high-intensity licenses, up to no more than one high-intensity license (1/2 acre) per applicant.

    If there remains a shortage of applicants to assure adequate production, the recommendation is to continue issuing licenses for additional acreage in the same order:

    (1) outdoor licenses in excess of one acre per applicant;
    (2) indoor mixed lighting in excess of one acre;
    (3) indoor high-intensity – firm cap of one acre maximum per applicant.

    Read Cal NORML’s full comments.

    Also see: Lawmakers say California’s proposed marijuana rules will hurt small family farms

    California NORML is a non-profit membership organization dedicated to protecting the interests of cannabis consumers by legalizing, taxing and regulating marijuana for adult use in California.

  • by Justin Strekal, NORML Political Director November 29, 2017

    Congressman Dana Rohrabacher (R-CA) addresses NORML members in September, 2017

    Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.

    This comes on the same day the Attorney General Jeff Sessions held a press conference to discuss America’s opioid epidemic and made disparaging comments about marijuana.

    “We’re working on that very hard right now,” Sessions said on Wednesday. “We had meetings yesterday and talked about it at some length. It’s my view that the use of marijuana is detrimental and we should not give encouragement in any way to it. And it represents a federal violation which is in the law and is subject to being enforced, and our priorities will have to be focused on all the things and challenges that we face.”

    From Rep. Rohrabacher’s press release:

    Representatives Dana Rohrabacher (CA-48) and Earl Blumenauer (OR-03) spearheaded a letter, signed by 64 other members of the House of Representatives, urging House and Senate leadership to ensure the inclusion of medical marijuana protections in any appropriations bill that funds the government beyond December 8, 2017. The provision, previously known as “Rohrabacher-Farr,” and now “Rohrabacher-Blumenauer,” bars the Department of Justice from using appropriated funds to prosecute individuals who are acting in compliance with their state’s medical marijuana laws. The provision was first signed into law in December 2014 as part of a larger spending package, and has been in force ever since.

    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    In September, President Donald Trump reached an agreement with Congressional leadership to enact a three-month continuing resolution that maintains present federal spending levels and priorities through December 8, 2017, which included the amendment that was passed in the previous session of Congress.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    It is imperative that the Rohrabacher-Blumenauer amendment remain the law of the land and AG Sessions not be given the green-light to enact a crackdown. Click here to send a message to your federal lawmakers and urge them to speak out about the need to protect the 2 million registered medical marijuana patients throughout the country.

  • by Justin Strekal, NORML Political Director
    Rick Steves with Illinois NORML's Ali Nagib

    Rick Steves with Illinois NORML’s Ali Nagib

    On Tuesday, travel radio and television host Rick Steves, a NORML Board Member, journeyed to Illinois to testify in support of marijuana legalization effort in the state legislature.

    “When you legalize marijuana, use does not go up, teen use does not go up, crime does not go up, what goes up ix tax revenue, what goes down is the black market,” Steves said. “Seventy thousand people are locked up in our country every year, 700,000 people are arrested, for possession of marijuana, not violent crimes. They’re not rich white guys, they’re poor people and they’re black people. It’s amazing that it’s happening in our country right now and there is just a way out of this.”

    Steves is well known for his public support of reform and has dedicated a tremendous amount of time and energy in support of outright legalization. During his press conference in Chicago, he was flanked by state lawmakers who have introduced the legislation. In their remarks, they laid out the economic realities of prohibition.

    “It is clear that prohibition doesn’t work and that by lifting cannabis restrictions we can encourage economic development in Illinois,” State Senator Heather Steans (D-Chicago) said. “We are carefully considering all aspects and potential impacts of legalizing adult-use cannabis, including job growth.”

    “Legalizing cannabis will spur the creation of new small businesses and much-needed jobs,” State Representative Kelly Cassidy (D-Chicago) said. “We are leaving hundreds of millions of dollars in economic activity on the table by continuing the outdated status quo of prohibition.”

    A recent poll of Illinois voters shows that 66% support the outright legalization of marijuana, and 74% support an end to arrests and penalties for simple possession.

    You can watch the press conference by clicking here.

    Make sure to follow Illinois NORML on Facebook, Twitter, and visit their website: https://illinoisnorml.org/

  • by Paul Armentano, NORML Deputy Director November 28, 2017

    Canadian parliamentMembers of the Canadian House of Commons voted 200 to 82 to approve legislation that seeks to legalize and regulate the adult use cannabis market. Liberal Party members, including Prime Minister Justin Trudeau, back the measure, which now faces debate in the Senate.

    The Cannabis Act, Bill C-45, amends the federal Controlled Drugs and Substances Act so that those over the age of 18 may legally possess, purchase, and grow personal use quantities of cannabis. It further seeks to establish rules and regulations governing the commercial production of retail cannabis products. Proponents of the legislation hope to have the new law in place by July 1, 2018.

    Health Canada is presently seeking public feedback regarding the regulations. Written comments will be accepted through January 20, 2018.

    Additional information regarding C-45 is available from NORML Canada. Updates regarding the text and status of the legislation is available from the Library of Parliament here.

Page 1 of 13212345...102030...Last »